EUVIMEDEUVIMED entdecken
Crossref

Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways

WanLin Wang

Pakistan Journal of Pharmaceutical Sciences · 12.11.2026

DOI: 10.36721/pjps/2026.40.16377.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, online erschienen am 12.11.2026. Verfasst von WanLin Wang. Die Arbeit nennt 55 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic immune-mediated inflammation remains difficult to treat with single-target approaches. Terpenoids are known to modulate immune responses, but whether specific combinations can produce enhanced effects and through which mechanisms is not well understood.

Objectives

This study investigates whether a fixed-ratio combination (5:23:26) of (-)-Linalool, (-)-Borneol and β-Caryophyllene (Formula 1) exerts enhanced anti-inflammatory effects and explores the underlying molecular mechanisms.

Methods

Two complementary models were used: release of slow-reacting substance of anaphylaxis (SRS-A) in isolated guinea pig ileum and LPS-activated RAW264.7 macrophages. PGE2, LTB4, NO and iNOS levels were measured. Network pharmacology, followed by experimental validation, identified key targets and pathways. Cellular morphology, apoptosis and NF-κB p65 nuclear accumulation were assessed by Hoechst 33342/PI staining and fluorescent plasmid transfection.

Results

Formula 1 achieved 79.88% inhibition of SRS-A release, significantly surpassing every single component (P < 0.001) and the positive control quercetin. It also reduced PGE2, LTB4, NO and iNOS levels more effectively than any single compound. In LPS-stimulated macrophages, Formula 1 reduced cell deformation and apoptosis and markedly reduced p65 nuclear translocation. Mechanistically, it increased the Nrf2/HO-1 axis while down-regulating NF-κB and the arachidonic acid pathway. Notably, even when (-)-Linalool was reduced to one-tenth of its dose, Formula 1 maintained comparable efficacy.

Conclusions

The combination of (-)-Linalool, (-)-Borneol and β-Caryophyllene produces enhanced anti-inflammatory effects through coordinated regulation of multiple pathways, as supported by the Highest Single Agent (HSA) model. These findings provide a basis for developing multi-target therapies for immune-mediated inflammatory diseases

Zitieren

APA

Wang, W. (2026). Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps/2026.40.16377.1

Vancouver

Wang W. Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways. Pakistan Journal of Pharmaceutical Sciences. 2026. doi:10.36721/pjps/2026.40.16377.1

BibTeX
@article{Wang2026,
  author = {Wang, WanLin},
  title = {Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways},
  journal = {Pakistan Journal of Pharmaceutical Sciences},
  year = {2026},
  doi = {10.36721/pjps/2026.40.16377.1}
}
Kostenlos starten →